Sixty seconds on . . . psilocybin
BMJ May 18, 2016 DOI: 10.1136/bmj.i2775 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Patients with treatment-resistant depression |
| Intervention | Psilocybin |
| Duration | Three-month follow-up |
| Topics | Psilocybin |
| Keywords | Magic telescope Depression economics Psychoanalysis Hallucinogen Psychotherapist Keynesian economics |
| Citations | 5 |
| Key findings | Psilocybin may be effective against treatment-resistant depression, with over 40% of patients in remission three months after treatment. |
Abstract
Not so fast. There’s a long way to go. But a study in London has shown that the active ingredient in magic mushrooms, psilocybin, may be effective against treatment resistant depression. Its effects were quick—within a week—and more than 40% of the patients treated were still in remission three months later.1 Yes, as far as it goes. These were people whose depression had …